Drug Shortage Report for APO-PANTOPRAZOLE
Report ID | 17296 |
Drug Identification Number | 02292920 |
Brand name | APO-PANTOPRAZOLE |
Common or Proper name | PANTOPRAZOLE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | PANTOPRAZOLE |
Strength(s) | 40MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL |
Packaging size | 500 BTL |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-07-31 |
Actual start date | 2017-07-31 |
Estimated end date | 2017-09-15 |
Actual end date | 2017-08-25 |
Shortage status | Resolved |
Updated date | 2017-08-28 |
Company comments | APO-PANTOPRAZOLE Na ECT 40MG 100 BTL available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2017-08-28 | French | Compare |
v5 | 2017-08-28 | English | Compare |
v4 | 2017-07-31 | French | Compare |
v3 | 2017-07-31 | English | Compare |
v2 | 2017-07-26 | French | Compare |
v1 | 2017-07-26 | English | Compare |
Showing 1 to 6 of 6